This inventor holds 2 USPTO granted patents. Top assignees: Boehringer Mannheim Pharmaceuticals Corporation - Smithkline Beecham, Boehringer Mannheim Pharmaceuticals Corporation Smith Kline Corporation. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Philadelphia, PA (US) (1998)
- Rosemont, PA (US) (1999)
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 1998-1999
Title: Mary Ann Lukas-Laskey: Innovator in Cardiac Treatment
Introduction
Mary Ann Lukas-Laskey is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of congestive heart failure. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Her latest patents include innovative methods for treating congestive heart failure. One patent focuses on the use of carbazole compounds for this treatment, while another outlines a method aimed at decreasing mortality resulting from congestive heart failure. These patents demonstrate her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Mary Ann has worked with notable companies such as Boehringer Mannheim Pharmaceuticals Corporation and SmithKline Beecham. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.
Collaborations
Mary Ann has collaborated with esteemed colleagues, including Robert Ruffolo, Jr. and Gisbert Sponer. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Mary Ann Lukas-Laskey is a trailblazer in the field of cardiac treatment, with her patents paving the way for new therapeutic approaches. Her dedication to innovation and collaboration highlights her significant role in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile